Viva Cyte Software-Suite-Plattform vum Livia Stevenin

D'Wierk Viva Cyte Software-Suite-Plattform vum Designer Livia Stevenin ass en héich geschätzten Gewënner vum prestigiéisen 2025 A' Design Award an Sëlwer an der Wettbewerbskategorie Interface, Interaktioun a Benotzererfaarung Design.

SëlwerInterface· 2025

Viva Cyte Software-Suite-Plattform

vum Livia Stevenin

Client: Cellply

A' Design Award an Sëlwer Gewënner an der Kategorie Interface

55,368

Verifizéierte Präisgewënner

Präisstatus fir #168358 verifizéieren

Säit besichen Kuckt beim A' Design Award Pressemëtteelung Award Badge

Faarwen

Den Design

Iwwer Viva Cyte Software-Suite-Plattform

Viva Cyte ass eng fortgeschridden Software-Plattform, déi entwéckelt gouf fir d'Entwécklung vun der Zelltherapie ze rationaliséieren andeems se Automatiséierung, High-Throughput-Analyse an eng intuitiv Benotzererfaarung integréiert. Si besteet aus Kontroll-Software (CSW) fir biologesch Tester ze verwalten an Analytesch Software (ASW) fir bedeitungsvoll Erkenntnisser ze extrahéieren. KI-gesteierten Automatiséierung reduzéiert mënschlech Feeler, verbessert d'Genauegkeet a verstäerkt d'Benotzbarkeit, wat et Fuerscher erlaabt komplex Aarbechtsofleef effizient ze navigéieren an therapeutesch Fortschrëtter ze beschleunegen.

D'Unerkennung

Iwwer den A' Design Award an Sëlwer

Viva Cyte Software-Suite-Plattform ass e Gewënner vum A' Design Award an Sëlwer, enger aussergewéinlech prestigiéiser Unerkennung, déi un Designe vun der héchster Qualitéit, prächteg a beandrockend vergi gëtt. Sëlwer-Gewënner si bemierkenswäert brillant a ganz kreativ Wierker, déi d'erausragend Expertise, d'Talent an d'Schaarfsënnegkeet vun hire Designer weisen. Et gëtt erwaart, datt Viva Cyte Software-Suite-Plattform e wonnerbart, mustergëlteg, bemierkenswäert professionellt an déif innovatiivt Wierk ass. Dëst mam Sëlwer ausgezeechent Design ass eng bemierkenswäert, bewonnert Erfindung, déi dozou bäidréit, d'Grenze vun der Konscht, der Wëssenschaft, vum Design an der Technologie ze erweideren. Viva Cyte Software-Suite-Plattform ass eng Kreatioun, op déi vill neidesch sinn, déi Wënsch erweckt, positiv Gefiller bréngt an Erstaunen a Wonner erweckt.

Hannert dem Design

Press Kit

Credits, Teammemberen an technesch Detailer vum Designer zur Verfügung gestallt.

Eenzegaarteg Eegeschaften: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Dimensiounen & Verpackung: Design: Figma
Front-end: React JS
Design System: Bento
Tags: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Produktiounstechnologie: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Design Erausfuerderung: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Fuerschung: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Inspiratioun: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Projetdauer: The project started in January 2022 in Milan and finished in August 2024.
Operatiounsablaf: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Teammemberen: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Bildnoweis: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),